FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
EC-18, 221139-79-3, EC-18 Intermediate 542-44-9, stock 994.7g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
EC-18, 221139-79-3, EC-18 Intermediate 69256-58-2, stock 311.5g, white powder, assay by HPLC 98%, HNMR, LCMS we supply. |
EC-18, 221139-79-3, EC-18 Intermediate 60-33-3, stock 298.1g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
EC-18, 221139-79-3, EC-18 Intermediate 920271-16-5, stock 396g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
EC-18, 221139-79-3, EC-18 Intermediate /, stock 112.6g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |